EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)

Xin-Yi Huang, Chao-Qun Yu, Xin Wang, Zhen Guo, Cheng-Hua Jin

Expert Opinion on Therapeutic Patents · 04.05.2026 · 36 (5) · 401-433

DOI: 10.1080/13543776.2026.2660906 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Opinion on Therapeutic Patents, online erschienen am 19.04.2026. Verfasst von Xin-Yi Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China. Hauptthemen laut MEDLINE: Receptor, Transforming Growth Factor-beta Type I, Protein Kinase Inhibitors. Die Arbeit nennt 136 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Transforming Growth Factor-beta Type IProtein Kinase InhibitorsHumansPatents as TopicAnimalsDrug DevelopmentSignal TransductionTransforming Growth Factor beta

Stichwörter der Autor:innen

ALK5 inhibitorTGF-βcancerfibrosispatent reviewsmall-molecule inhibitor

Substanzen

Receptor, Transforming Growth Factor-beta Type ITGFBR1 protein, humanProtein Kinase InhibitorsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, X. Y., Yu, C. Q., Wang, X., Guo, Z., & Jin, C. H. (2026). Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present). Expert Opinion on Therapeutic Patents, 36(5), 401-433. https://doi.org/10.1080/13543776.2026.2660906

Vancouver

Huang XY, Yu CQ, Wang X, Guo Z, Jin CH. Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present). Expert Opinion on Therapeutic Patents. 2026;36(5):401-433. doi:10.1080/13543776.2026.2660906

BibTeX
@article{Huang2026,
  author = {Huang, Xin-Yi and Yu, Chao-Qun and Wang, Xin and Guo, Zhen and Jin, Cheng-Hua},
  title = {Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)},
  journal = {Expert Opinion on Therapeutic Patents},
  year = {2026},
  volume = {36},
  number = {5},
  pages = {401--433},
  doi = {10.1080/13543776.2026.2660906}
}
Kostenlos starten →